1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Mental Health Market Trends
  5. > Mental Health Analysis & Statistics, July 2019

Mental Health Analysis & Statistics, July 2019

Customer Support

Talk to Ahmad

+1 718 618 4302

Publishers

  • All
    • Renub Research

data types

1-4 of 4 reports

Epilepsy Drugs Market by Country (US, UK, France, etc), Drugs (Vimpat, Keppra, Sabril, Onfi, etc), Treatment Drugs Generation (First, Second, Third), Companies & Forecast

Epilepsy Drugs Market by Country (US, UK, France, etc), Drugs (Vimpat, Keppra, Sabril, Onfi, etc), Treatment Drugs Generation (First, Second, Third), Companies & Forecast

  • $ 1995
  • Industry report
  • February 2019

Epilepsy Drugs Market by Country (US, UK, France, etc), Drugs (Vimpat, Keppra, Sabril, Onfi, etc), Treatment Drugs Generation (First, Second, Third), Companies & ForecastEpilepsy is a chronic disease in ...

  • Industries : Mental Health, Pathology
  • Countries : World
Spinal Muscular Atrophy Market Global Forecast by Countries, Drugs, Companies

Spinal Muscular Atrophy Market Global Forecast by Countries, Drugs, Companies

  • $ 2190
  • Industry report
  • November 2018

Spinal Muscular Atrophy Market Global Forecast by Countries (United States, United Kingdom, France, Germany, Spain, Italy & Japan), Drugs (Spinraza, AVXS-101, CK2127107, RG7916, Olesoxime & LMI070), Companies ...

  • Industries : Mental Health
  • Countries : World
Europe Multiple Sclerosis Market, Patients By (United Kingdom, Germany, France, Italy, Spain) By (Injectables, Infusion, Orals)

Europe Multiple Sclerosis Market, Patients By (United Kingdom, Germany, France, Italy, Spain) By (Injectables, Infusion, Orals)

  • $ 1400
  • Industry report
  • October 2017

According to Renub Research Europe Multiple Sclerosis Market potential is more than US$ 5 Billion by 2022.But only more than half this market is expected to be actually achieved. This huge difference between ...

  • Industries : Mental Health, Pathology
  • Countries : Europe, World
Global Multiple Sclerosis Market, Patient Numbers & Forecast (By Mode of Administration: Injectables Market, Infusions Market, Orals Market) – Actual & Unmet (Potential)

Global Multiple Sclerosis Market, Patient Numbers & Forecast (By Mode of Administration: Injectables Market, Infusions Market, Orals Market) – Actual & Unmet (Potential)

  • $ 1599
  • Industry report
  • September 2017

Global Multiple Sclerosis Market, Patient Numbers & Forecast (By Mode of Administration: Injectables Market, Infusions Market, Orals Market) – Actual & Unmet (Potential) published by Renub Research on ...

  • Industries : Mental Health, Pathology
  • Countries : World, United States



Reportlinker.com © Copyright 2019. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on